On Sunday, Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that the FDA has placed a clinical hold on its prospective Phase 3 pivotal trial evaluating …
H.C.
Alkermes Plc All eyes today on Alkermes Plc (NASDAQ:ALKS) as the biopharmaceutical company announced positive phase 3 data for ALKS 5461, a pipeline drug …
TG Therapeutics Inc (NASDAQ:TGTX) shares crashed almost 17% yesterday on back of the biotech firm’s announcement that it has filed with the FDA …
Analysts are weighing in on today’s biggest gainers and losers: HTG Molecular Diagnostics Inc (NASDAQ:HTGM) and Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC). While one analyst considers HTGM as …
In a research report released today, H.C.
On Tuesday, Galectin Therapeutics Inc (NASDAQ:GALT) reported that its pipeline investigational drug GR-MD-02, designed to treat liver fibrosis, missed its primary endpoint in …
